Insulin-like growth factor 1 (IGF-1), implicated as a potent, pro-fibrotic, fibroblast growth factor in the context of IPF and bleomycin-induced fibrosis, was increased in the BLEO group, and reduced in the BLEO+EX group (Fig 3F). Here, IGF1 is linked to idiopathic pulmonary fibrosis.